Menú

ISAC
ISAC (Intervencions Sanitàries i Activitats Comunitàries)

Responsable del grupo
avatar_investigadors.jpg
Francisco Martín Luján
avatar_grups_recerca.png

Projectes

Proyectos del grupo

Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine

  • Investigadores principales: Felipe Villalobos Martínez
  • Código: 4R21/037
  • Año de inicio: 2021
  • Financiadores: Fondazione Penta ETS

Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (WP3)

  • Investigadores principales: Felipe Villalobos Martínez
  • Código: 4R21/065
  • Año de inicio: 2021
  • Financiadores: Vaccine Monitoring Collaboration for Europe (VAC4EU)

Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe

  • Investigadores principales: Felipe Villalobos Martínez
  • Código: 4R21/080
  • Año de inicio: 2021
  • Financiadores: ICS - Institut Català de la Salut, Julius Clinical Research B.V.

Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (WP1)

  • Investigadores principales: Felipe Villalobos Martínez
  • Código: 4R21/109
  • Año de inicio: 2021
  • Financiadores: European Medicines Agency (EMA)

Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries

  • Investigadores principales: Felipe Villalobos Martínez
  • Código: 4R21/110
  • Año de inicio: 2021
  • Financiadores: Julius Clinical Research B.V.